FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Comparision between Jaypee Infratech IPO and Parabolic Drugs IPO.
Jaypee Infratech IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Parabolic Drugs IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.
Jaypee Infratech IPO | Parabolic Drugs IPO | |
---|---|---|
Logo | ||
Issue Category | Mainline | Mainline |
Issue Type | IPO | IPO |
Process Type | Book Built Issue | Book Built Issue |
Listing At | BSE, NSE | BSE, NSE |
Lead Managers | Axis Bank Limited Bofa Securities India Limited Axis Capital Limited ICICI Securities Limited Morgan Stanley India Company Pvt Ltd |
ICICI Securities Limited Spa Capital Advisors Ltd |
Registrar | Kfin Technologies Limited | Link Intime India Private Ltd |
Market Maker | ||
DRHP | DRHP | DRHP |
RHP | RHP | RHP |
Anchor Investor | ||
IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Jaypee Infratech IPO is up to ₹1,650.00 Cr whereas the issue size of the Parabolic Drugs IPO is up to ₹200.00 Cr. The final issue price of Jaypee Infratech IPO is ₹102.00 per share and of Parabolic Drugs IPO is ₹75.00 per share.
Jaypee Infratech IPO | Parabolic Drugs IPO | |
---|---|---|
Face Value | ₹10 per share | ₹10 per share |
Issue Price (Lower) | ₹102.00 per share | ₹75.00 per share |
Issue Price (Upper) | ₹117.00 per share | ₹85.00 per share |
Issue Price (Final) | ₹102.00 per share | ₹75.00 per share |
Discount (Retail) | ||
Discount (Employee) | ||
Market Lot Size | 50 shares | 80 shares |
Fresh Issue Size | ||
Fresh Issue Size (Amount) | ||
OFS Issue Size | ||
OFS Issue Size (Amount) | ||
Issue Size Total | 16,29,33,497 shares | 2,66,66,667 shares |
Issue Size Total (Amount) | up to ₹1,650.00 Cr | up to ₹200.00 Cr |
Jaypee Infratech IPO opens on Apr 29, 2010, while Parabolic Drugs IPO opens on Jun 14, 2010. The closing date of Jaypee Infratech IPO and Parabolic Drugs IPO is May 04, 2010, and Jun 17, 2010, respectively.
Jaypee Infratech IPO | Parabolic Drugs IPO | |
---|---|---|
Anchor Bid Date | ||
Issue Open | Apr 29, 2010 | Jun 14, 2010 |
Issue Close | May 04, 2010 | Jun 17, 2010 |
Basis Of Allotment (Tentative) | ||
Initiation of Refunds (Tentative) | ||
Credit of Share (Tentative) | ||
Listing date (Tentative) | ||
Anchor Lockin End date 1 | ||
Anchor Lockin End date 2 |
Jaypee Infratech IPO P/E ratio is , as compared to Parabolic Drugs IPO P/E ratio of .
Jaypee Infratech IPO | Parabolic Drugs IPO | |||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial |
|
|
||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Pre-Issue) | 99.1% | 63.2% | ||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Post-Issue) | 83.05% | 46.5% | ||||||||||||||||||||||||||||||||||||||||||||
P/E Ratio | ||||||||||||||||||||||||||||||||||||||||||||||
Market Cap | ||||||||||||||||||||||||||||||||||||||||||||||
ROE | ||||||||||||||||||||||||||||||||||||||||||||||
ROCE | 6.21%% | |||||||||||||||||||||||||||||||||||||||||||||
Debt/Equity | ||||||||||||||||||||||||||||||||||||||||||||||
EPS | ||||||||||||||||||||||||||||||||||||||||||||||
RoNW | 21.42%% | 19.96%% |
In the Jaypee Infratech IPO retail investors (RII) are offered 5,98,76,470 shares while in Parabolic Drugs IPO retail investors are offered 5,98,76,470 shares. Qualified institutional buyers (QIB) are offered 11,97,52,941 shares in Jaypee Infratech IPO and 1,30,83,333 shares in Parabolic Drugs IPO.
Jaypee Infratech IPO | Parabolic Drugs IPO | |
---|---|---|
Anchor Investor Reserveration | ||
Market Maker Reserveration | ||
QIB | 11,97,52,941 shares | 1,30,83,333 shares |
NII | 1,99,58,824 shares | 39,25,000 shares |
RII | 5,98,76,470 shares | 91,58,334 shares |
Employee | 0 shares | 5,00,000 shares |
Others | ||
Total | 22,17,64,705 shares | 2,66,66,667 shares |
Jaypee Infratech IPO subscribed 1.24x in total, whereas Parabolic Drugs IPO subscribed 1.04x.
Jaypee Infratech IPO | Parabolic Drugs IPO | |
---|---|---|
QIB (times) | 1.77x | 1.48x |
NII (times) | 1.15x | 1.20x |
Big NII (times) | ||
Small NII (times) | ||
RII (times) | 0.61x | 0.40x |
Employee (times) | 0.11x | |
Other (times) | 0.10x | |
Total (times) | 1.24x | 1.04x |
Add a public comment...
Rs 0 Account Opening Fee
Free Eq Delivery & MF
Flat ₹20 Per Trade in F&O
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|